Freedberg Jared 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Feb 1, 2021
Insider Transaction Report
Form 4
Freedberg Jared
General Counsel and Secretary
Transactions
- Award
Option to Purchase Common Stock
2021-02-01+69,400→ 69,400 totalExercise: $36.90Exp: 2031-02-01→ Common Stock (69,400 underlying) - Award
Common Stock
2021-02-01+44,277→ 44,277 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and the remaining shares vesting pro rata on each subsequent three-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date is February 1, 2021.
- [F2]The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is February 1, 2021.